住院儿科患者静脉注射对乙酰氨基酚与静脉阿片类药物使用时长的关联
该比较效果研究利用2011年1月至2016年6月美国274家医院的国家数据库,纳入104 579例住院儿科患者,比较静脉阿片前使用静脉对乙酰氨基酚(干预组)与单纯静脉阿片(对照组)的静脉阿片总时长。经倾向评分匹配后每组839例,多变量模型估计干预组静脉阿片使用时长缩短15.5%,绝对减少7.5小时(95%CI 0.7-15.8小时)。作者认为,在静脉阿片前使用静脉对乙酰氨基酚的多模式镇痛方案可缩短静脉阿片使用时长。
要点
- 在住院儿科患者中,静脉阿片前给予静脉对乙酰氨基酚与静脉阿片总时长缩短15.5%相关。
- 匹配后干预组较对照组静脉阿片绝对减少7.5小时(95%CI 0.7-15.8小时)。
- 干预组1739例(10.8%)在静脉阿片前接受静脉对乙酰氨基酚,中位治疗时间1.5小时(IQR 0.02-7.3小时)。
- 作者认为,在静脉阿片前使用静脉对乙酰氨基酚的多模式镇痛方案可缩短静脉阿片使用时长。
适用人群与场景
- 美国274家医院2011年1月至2016年6月收治的住院儿科患者,来自国家数据库。
- 纳入分析104 579例,中位年龄1.3岁(IQR 0-14.7岁),59 806例(57.2%)女性,21 485例(21.5%)非裔美国人,56 309例(53.8%)白人。
- 干预组为静脉阿片前接受静脉对乙酰氨基酚者,对照组为接受静脉阿片但未用静脉对乙酰氨基酚者。
处置流程与药物剂量
- 干预措施为在静脉阿片给药前给予静脉对乙酰氨基酚;原文未给出具体剂量、给药频次或疗程。
研究设计与关键结果
- 研究类型为比较效果研究,数据来自美国274家医院2011年1月至2016年6月的国家数据库,纳入住院儿科患者104 579例。
- 在893 293例儿科住院患者中,18 197例(2.0%)接受静脉对乙酰氨基酚,287 504例(34.0%)接受静脉阿片。
- 接受静脉对乙酰氨基酚的患者中,1739例(10.8%)在静脉阿片前给药,中位治疗时间1.5小时(IQR 0.02-7.3小时)。
- 倾向评分匹配后干预组与对照组各839例,多变量模型估计干预组静脉阿片使用时长缩短15.5%,绝对减少7.5小时(95%CI 0.7-15.8小时)。
证据类型、等级与局限
- 证据类型:比较效果研究,基于国家数据库的倾向评分匹配分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在静脉阿片前使用静脉对乙酰氨基酚的多模式镇痛方案可缩短静脉阿片使用时长。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Adoption of multimodal pain regimens that incorporate nonopioid analgesic medications to reduce inpatient opioid administration can prevent serious opioid-related adverse effects in children, including tolerance, withdrawal, delirium, and respiratory depression. Intravenous (IV) acetaminophen is in widespread pediatric use; however, its effectiveness as an opioid-sparing agent has not been evaluated in general pediatric inpatients.
OBJECTIVE: To determine if IV acetaminophen administered prior to IV opioids is associated with a reduction in the total duration of IV opioids administered compared with IV opioids administered without IV acetaminophen in general pediatric inpatients.
DESIGN, SETTING, AND PARTICIPANTS: This comparative effectiveness research study included data on pediatric inpatients from 274 US hospitals between January 2011 and June 2016 collected from a national database. Outcomes were compared with a propensity score-matched analysis of pediatric inpatients administered IV opioids without IV acetaminophen (control) and those administered IV acetaminophen prior to IV opioids (intervention). Data were analyzed from January 2020 through October 2021.
EXPOSURES: Patients in the intervention group received IV acetaminophen prior to IV opioids. Patients in the control group received IV opioids without IV acetaminophen.
MAIN OUTCOMES AND MEASURES: Total duration of all IV opioids administered during a patient's hospitalization.
RESULTS: Of 893 293 pediatric inpatients, a total of 104 579 were included in analysis (median [IQR] age, 1.3 [0-14.7] years; 59 806 [57.2%] female; 21 485 [21.5%] African American, 56 309 [53.8%] White), of whom 18 197 (2.0%) received IV acetaminophen, and 287 504 (34.0%) received IV opioids. After applying exclusion criteria, among patients who received IV acetaminophen, 1739 (10.8%) received IV acetaminophen prior to IV opioids within a median (IQR) treatment time of 1.5 (0.02-7.3) hours. After propensity score matching produced comparable groups in the control and intervention groups (with 839 patients in each group), the multivariable model estimated a 15.5% shorter duration of IV opioid use in the intervention group, with an absolute IV opioid reduction of 7.5 hours (95% CI, 0.7-15.8 hours).
CONCLUSIONS AND RELEVANCE: In this comparative effectiveness study, IV acetaminophen administered prior to IV opioids was associated with a reduction in IV opioid duration by 15.5%. Multimodal pain regimens that use IV acetaminophen prior to IV opioids could reduce IV opioid duration.
参考来源
- Patel AK, Gai J, Trujillo-Rivera E, et al. Association of Intravenous Acetaminophen Administration With the Duration of Intravenous Opioid Use Among Hospitalized Pediatric Patients. JAMA Netw Open. 2021. PMID: 34932106. doi:10.1001/jamanetworkopen.2021.38420
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。